RIGEL PHARMACEUTICALS INC Annual Earnings Per Share, Basic in USD/shares from 2010 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Rigel Pharmaceuticals Inc quarterly/annual Earnings Per Share, Basic history and growth rate from 2010 to 2023.
  • Rigel Pharmaceuticals Inc Earnings Per Share, Basic for the quarter ending September 30, 2024 was 0.71 USD/shares.
  • Rigel Pharmaceuticals Inc Earnings Per Share, Basic for the twelve months ending September 30, 2024 was 1.25 USD/shares.
  • Rigel Pharmaceuticals Inc annual Earnings Per Share, Basic for 2023 was -0.14 USD/shares, a 58.8% increase from 2022.
  • Rigel Pharmaceuticals Inc annual Earnings Per Share, Basic for 2022 was -0.34 USD/shares, a 209% decline from 2021.
  • Rigel Pharmaceuticals Inc annual Earnings Per Share, Basic for 2021 was -0.11 USD/shares, a 38.9% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 +$0.20 +58.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $0 $0 -209% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $0 +$0.07 +38.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 $0 +$0.22 +55% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-07
2019 $0 Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2012 -$1 +$0.04 +2.94% Jan 1, 2012 Dec 31, 2012 10-K 2013-03-05
2011 -$1 -$2 -286% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-05
2010 $0.73 Jan 1, 2010 Dec 31, 2010 10-K 2013-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.